missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human CETP (aa 149-159) Synthetic Peptide
Description
CETP (residues 149-159) Synthetic Peptide, PEP-209, from Invitrogen.
It has been proposed that high density lipoproteins (HDLs) function jointly with lecithin:cholesterol acyltransferase and CETP to facilitate cholesterol transport from tissues to the liver. This mechanism, referred to as reverse cholesterol transport, is physiologically important because it maintains systemic cholesterol levels. CETP is responsible for neutral lipid transfer activity in plasma in numerous species. Since CETP is able to accelerate specifically the exchange of lipid components between pro- and anti-atherogenic lipoprotein fractions, it may be a key determinant of the global atherogenicity of the plasma lipoprotein profile and arises as a possible target in atherosclerosis prevention. CETP has an important role in reverse cholesterol transport and shaping and affecting the composition of plasma lipoproteins. In general elevated levels of CETP have been associated with increased risk of coronary heart disease.
Specifications
Specifications
| Gene ID (Entrez) | 1071 |
| Species | Human |
| Purification Method | purified |
| Accession Number | P11597 |
| Common Name | Human CETP (aa 149-159) |
| Concentration | 0.5 mg/mL |
| Content And Storage | -20°C. Avoid freeze-thaw cycles. |
| Description | Synthetic Peptide |
| Format | Lyophilized |
| Formulation | peptide with no preservative |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?